ANI Pharmaceuticals Inc (ANIP NASDAQ) stock market data APIs
$70.2372
1.82(2.6%)
as of March 13, 2026
Try our APIs with
free plan!
ANI Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Prev. Close
70.2372
Open
72.0525
High
72.5896
Low
69.5371
52 wk Range
56.71-99.5
Market Cap
1 583 M
P/E Ratio
21.2319
Shares Outstanding
22 414 K
Revenue
883 M
EPS
2.33
Beta
0.462
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with ANI Pharmaceuticals Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get ANI Pharmaceuticals Inc data using free add-ons & libraries
Get ANI Pharmaceuticals Inc Fundamental Data
ANI Pharmaceuticals Inc Fundamental data includes:
- Net Revenue: 883 M
- EBITDA: 175 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-02-26
- EPS/Forecast: 2.04
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
ANI Pharmaceuticals Inc News
New
4 Biotech Stocks to Watch for Potential Upside in 2026
The biotech industry has delivered an upbeat performance so far in 2026 despite an uncertain macroeconomic backdrop. Strong fourth-quarter results, better visibility, new drug approvals and encouragin...
United Therapeutics Stock Surges 32% in 6 Months: Here's Why
Shares of United Therapeutics UTHR have surged approximately 32% over the past six months, driven by strong commercial growth, a major clinical breakthrough and improved long-term growth visibility, w...
Allogene Therapeutics Posts Narrower-Than-Expected Loss in Q4
Allogene Therapeutics ALLO incurred a fourth-quarter 2025 loss of 17 cents per share, narrower than the Zacks Consensus Estimate of a loss of 25 cents. In the year-ago period, the company had reported...
Sizing Up ANI Pharmaceuticals (ANIP) After Recent Share Price Pullback
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. If you are wondering whether ANI Pharmaceuticals' current share price reflects its true wor...
Get ANI Pharmaceuticals Inc fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
